Informator o strukturze Uczelni

Rozwiń
Start > Organizacja uczelni  > Podstawowe jednostki strukturalne  > Wydział Lekarski  > Katedra Psychiatrii  > Klinika Psychiatrii Dorosłych

Klinika Psychiatrii Dorosłych

Katedra Psychiatrii

PUBLIKACJE (LISTA FILADELFIJSKA)

Publikacje w czasopismach z "listy filadelfijskiej" (z trzech ostatnich lat):

  1. Patients' voices on ketamine for treatment-resistant depression: a narrative review of qualitative perspectives - Walaszek Michał, CUBAŁA WIESŁAW JERZY, Kachlik Zofia - J. Clin. Med. - 2026 : vol. 15, nr 1, art. ID 150, s. 1-13, bibliogr. 32 poz., streszcz. ang.
  2. Rapid antidepressant effects of inhaled GH001 in treatment-resistant depression: results from a phase 2b, double-blind, randomized controlled trial with 6-month follow-up - Harding Lisa, Baune Bernhard, Brennan Brian, Cardoner Narcís, Duenas Herrero Rosa Maria, Gregory David, Janü Luboš, Kelly John, McInerney Shane, Nawka Alexander, Páleníček Tomáš, Pérez Sola Víctor, Reif Andreas, Ryan Fiona, Sweeney Claire, Thase Michael, Trivedi Madhukar, Valcheva Velichka, Vieta Eduard, CUBAŁA WIESŁAW - Neuropsychopharmacol. - 2026 : vol. 51, suppl. 1, s. 207
  3. Suicidal ideation and behavior in patients with treatment-resistant depression treated with GH001 - Mathew Sanjay, Baune Bernhard, Cardoner Narcís, CUBAŁA WIESŁAW, Doolin Kelly, Duenas Herrero Rosa Maria, Gregory David, Janů Luboš, Kelly John, MacIssac Rachael, McInerney Shane, Nawka Alexander, Páleníček Tomáš, Pérez Sola Víctor, Reif Andreas, Sweeney Claire, Trivedi Madhukar, Valcheva Velichka, Vieta Eduard, Thase Michael - Neuropsychopharmacol. - 2026 : vol. 51, suppl. 1, s. 199-200
  4. Rapid antidepressant effect of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) in treatment-resistant depression: a phase 2b double-blind study - Feifel David, Roberts Claire, CUBAŁA WIESŁAW JERZY, Gründer Gerhard, Duenas Herrero Rosa Maria, Hindocha Chandni, Liknaitzky Paul, McGuigan Sean, Mehta Sejal, Repantis Dimitris, Seynaeve Mathieu, Wiegand Frank, Conley Robert - Neuropsychopharmacol. - 2026 : vol. 51, suppl. 1, s. 167-168
  5. Cross-sectional analysis of ongoing clinical trials involving lamotrigine for mental disorders: insights from ClinicalTrials.gov and the EU clinical trials - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, CUBAŁA WIESŁAW JERZY - Psychiatr. Res. - 2026 : vol. 356, art. ID 116878, s. 1-13, bibliogr. [40] poz., streszcz. ang.
  6. Appetite measures as correlates of clinical response in mood disorders treated with ketamine: systematic review - SŁUPSKI JAKUB, MECHLIŃSKA AGNIESZKA, WŁODARCZYK ADAM, KWAŚNY ALEKSANDER, SZARMACH JOANNA, SŁUPSKA ANITA, CUBAŁA WIESŁAW JERZY - Front. Nutr. - 2025 : vol. 12, art. ID 1616859, s. 1-11, bibliogr. 49 poz., streszcz. ang.
  7. Amino acids, purines, and pyrimidines as potential biochemical markers of bipolar disorder - current state of knowledge - SADKO KRZYSZTOF G., WICHOWICZ HUBERT - Post. Psychiatr. Neurol. - 2025 : vol. 34, nr 2, s. 99-107, bibliogr. 38 poz., streszcz. ang.
  8. Measuring the effects of ketogenic diet on neuropsychiatric disorder: a scoping review - letter to the editor - MECHLIŃSKA AGNIESZKA, WŁODARCZYK ADAM - Prog. Neuropsychopharmacol. Biol. Psychiatr. - 2025 : vol. 136, art. ID 111246, s. 1-2, bibliogr. [8] poz., streszcz. ang.
  9. Schizophrenia and amino acids in diet - it is possible to enhance treatment through nutrition? - SADKO KRZYSZTOF GRZEGORZ, WICHOWICZ HUBERT, JABŁOŃSKA PATRYCJA, Wolszczak Anna - Psychiatr. Psychol. Klin. - 2025 : vol. 25, nr 2, s. 162-168, bibliogr. [47] poz., streszcz. ang., pol.
  10. Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: a cross-sectional analysis of protocols from ClinicalTrials.gov - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, SADKO KRZYSZTOF, Pruc Michal, Gaca Zuzanna, Szarpak Lukasz, CUBAŁA WIESŁAW JERZY - Psychiatr. Res. - 2025 : vol. 350, art. ID 116559, s. 1-11, bibliogr. [36] poz., streszcz. ang.
  11. Estrogen metabolites and hydrogen peroxide - missing elements in the pathophysiology and possible treatment of treatment-resistant depression? - Winczewska Zofia, MECHLIŃSKA AGNIESZKA, Radziwiłłowicz Piotr, KONIECZNA LUCYNA, Drzeżdżon Joanna, Jacewicz Dagmara, WIGLUSZ MARIUSZ, BĄCZEK TOMASZ, CUBAŁA WIESŁAW JERZY, GÓRSKA-PONIKOWSKA MAGDALENA - Redox Biol. - 2025 : vol. 81, art. ID 103547, s. 1-7, bibliogr. 79 poz., streszcz. ang.
  12. Defining treatment-resistant bipolar depression: recommendations from the ISBD Task Force - Vieta Eduard, McIntyre Roger S., Suppes Trisha, Van Rheenen Tamsyn E., Singh Balwinder, Woznica Miskowiak Kamilla, Young Allan H., Yatham Lakshmi N., Ha Kyooseob, Berk Michael, Swartz Holly A., Henry Chantal, Stefanovic Maja Pantovic, Diaz Gerard Anmella, Ozerdem Aysegul, CUBAŁA WIESŁAW J., Hidalgo-Mazzei Diego, Tohen Mauricio, Pacchiarotti Isabella, Nunes Paula Villela, Lopez-Jaramillo Carlos, Gonzalez-Pinto Ana, Brambilla Paolo, Post Robert, Soares Jair C., Bauer Michael, Andreazza Ana C., Fradera Xavier Justes, Cosials-Lopez Montserrat, Fico Giovanna - Bipolar Disord. - 2025 : vol. 27, nr 6, s. 411-423, bibliogr. 98 poz., streszcz. ang.
  13. Comment on "Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis" - WILKOWSKA ALINA, CUBAŁA WIESŁAW JERZY - Eur. Arch. Psychiatr. Clin. Neurosci. - 2025 : vol. 275, nr 5, s. 1525-1526, bibliogr. 8 poz.
  14. Racial and ethnic diversity in zuranolone and brexanolone clinical trials for postpartum depression: A cross-sectional analysis of ClinicalTrials.gov - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, Pruc Michal, Szarpak Lukasz, CUBAŁA WIESŁAW JERZY - Eur. Neuropsychopharmacol. - 2025 : vol. 96, s. 5-6, bibliogr. [5] poz.
  15. Top-line results from ESCAPE-LTE: an open-label extension study to assess long-term safety of esketamine nasal spray in treatment resistant depression - Godinov Y., Fu D. J., von Holt C., Buyze J., Mehta R., Reif A., Messer T., Bitter I., Frey R., Häggström L., Anil Yagcioglu A. E., Nielsen R., CUBAŁA WIESŁAW J. - Eur. Psychiatr. - 2025 : vol. 68, nr S1, abs. EPP649, s. S411
  16. The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force - Verdoux Hélène, Bittner Robert A., Hasan Alkomiet, Qubad Mishal, Wagner Elias, Lepetit Alexis, Arrojo-Romero Manuel, Bachmann Christian, Beex-Oosterhuis Marieke, Bogers Jan, Celofiga Andreja, Cohen Dan, De Berardis Domenico, de Hert Marc, De Las Cuevas Carlos, Ebdrup Bjørn H., Fountoulakis Konstantinos N., Guinart Daniel, Keating Dolores, Kopeček Miloslav, Lally John, Lazáry Judit, Luykx Jurjen J., Maronas Amigo Olalla, Molden Espen, Nielsen Jimmi, O'Donoghue Brian, Oswald Pierre, Radulescu Flavian S., Rohde Christopher, Sagud Marina, Sanz Emilio J., Šimunović Filipčić Ivona, Sommer Iris E., Taipale Heidi, Tiihonen Jari, Tuppurainen Heli, Veerman Selene, WILKOWSKA ALINA, Spina Edoardo, Schulte Peter - Eur. Psychiatr. - 2025 : vol. 68, nr 1, art. ID e17, s. 1-5, bibliogr. 10 poz., streszcz. ang.
  17. Ketamine in post-stroke depression: a report of 2 cases - WŁODARCZYK ADAM, SŁUPSKI JAKUB, SZARMACH JOANNA, Milewska Dominika, CUBAŁA WIESŁAW J. - Front. Psychiatry - 2025 : vol. 16, art. ID 1680687, s. 1-7, bibliogr. 29 poz., streszcz. ang.
  18. Machine learning prediction of suicide attempt counts in Poland: insights from Google trends and historical data - Walaszek Michał, Kachlik Zofia, NAZAR WOJCIECH, Sokołowska Monika, Karbiak Aleksander, Pilarska Eliza, WASZAK PRZEMYSŁAW, CUBAŁA WIESŁAW JERZY - Int. J. Clin. Health Psychol. - 2025 : vol. 25, nr 4, art. ID 100644, s. 1-9, bibliogr. [50] poz., streszcz. ang.
  19. The effect of ketamine on the immune system in patients with treatment-resistant depression - Szałach Łukasz P., CIESIELSKA-FIGLON KLAUDIA, DACA AGNIESZKA, CUBAŁA WIESŁAW J., LISOWSKA KATARZYNA A. - Int. J. Mol. Sci. - 2025 : vol. 26, nr 15, art. ID 7500, s. 1-17, bibliogr. 33 poz., streszcz. ang.
  20. IL-4, TSLP and IL-31 cytokine profiles as related to psychometric measures in patients with mastocytosis - ROMANTOWSKI JAN, FABIAŃCZYK KINGA, SKRZYPKOWSKA MARIA, CUBAŁA WIESŁAW J., TRZONKOWSKI PIOTR, NIEDOSZYTKO MAREK - Int. J. Mol. Sci. - 2025 : vol. 26, nr 2, art. ID 529, s. 1-9, bibliogr. 41 poz., streszcz. ang.
  21. Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, Pruc Michal, Gaca Zuzanna, Szarpak Lukasz, CUBAŁA WIESŁAW J. - Int. J. Psychiatr. Med. - 2025 : vol. 60, nr 6, s. 603-623, bibliogr. 33 poz., streszcz. ang.
  22. Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: an open-label extension study - CUBAŁA WIESŁAW J., Berrio Ana, Chi-Burris Katherine, Alva Gustavo, Chrones Lambros, Pathak Sanjeev - J. Alzheimers Dis. - 2025 : vol. 106, nr 2, s. 783-793, bibliogr. 27 poz., streszcz. ang.
  23. Predicting suicide attempt trends in youth: a machine learning analysis using Google Trends and historical data - Kachlik Zofia, Walaszek Michał, NAZAR WOJCIECH, Sokołowska Monika, Karbiak Aleksander, Pilarska Eliza, CUBAŁA WIESŁAW JERZY - J. Clin. Med. - 2025 : vol. 14, nr 18, art. ID 6373, s. 1-13, bibliogr. 40 poz., streszcz. ang.
  24. The need for guidance on ketamine/esketamine use in real-world clinical settings - WILKOWSKA ALINA, CUBAŁA WIESŁAW JERZY - J. Clin. Psychiatr. - 2025 : vol. 86, nr 2, art. ID 24lr15709, s. 1-2, bibliogr. 5 poz.
  25. From today's observations to tomorrow's standards in women's psychiatry - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, CUBAŁA WIESŁAW JERZY - J. Clin. Psychiatr. - 2025 : vol. 86, nr 4, art. ID 25lr16109, s. 1-2, bibliogr. 6 poz.
  26. Comments on 'Characterization of patients with atopic dermatitis based on flare patterns and severity of disease: a Danish population-based study' - Kachlik Zofia, Walaszek Michał, PASTUSZAK MICHAŁ - J. Eur. Acad. Dermatol. Venereol. - 2025 : vol. 39, nr 2, s. e202-e203, bibliogr. 9 poz.
  27. Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, Ciurkowska Patrycja, Pruc Michał, Szarpak Lukasz, CUBAŁA WIESŁAW JERZY - J. Psychopharmacol. - 2025 : vol. 39, nr 9, s. 1014-1022, bibliogr. [41] poz., streszcz. ang.
  28. Culture, context, and regulation in psychiatric trials : Commentary Koment. do: Reporting and representation of race and ethnicity in clinical trials of pharmacotherapy for mental disorders : a meta-analysis / Alessio Bellato, Joaquim Raduá, Antoine Stocker, Maude-Sophie Lockman, Anusha Lall, Vishnie Ravisankar, Emma Machell, Dalia Albiaa, Anna Cabras, Douglas Teixeira Leffa, Catarina Manuel, Valeria Parlatini, Assia Riccioni, Christoph U. Correll, Paolo Fusar-Poli, Marco Solmi, Samuele Cortese // JAMA Psychiatry 2025, vol. 82, nr 7, s. 663-670 - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, CUBAŁA WIESŁAW JERZY - JAMA Psychiatry - 2025 : vol. 82, nr 7, s. 663-670
  29. Residual fatigue in unipolar and bipolar depression: a systematic review - Pastuszak Michał, CUBAŁA WIESŁAW JERZY, JAKUSZKOWIAK-WOJTEN KATARZYNA, KWAŚNY ALEKSANDER, ŚWIECZKOWSKI DAMIAN, GAŁUSZKO-WĘGIELNIK MARIA - Neuropsychopharmacol. Rep. - 2025 : vol. 45, nr 1, art. ID e12519, s. 1-16, bibliogr. 53 poz., streszcz. ang.
  30. Nonresponse to ketamine in treatment-resistant bipolar depression - Kachlik Zofia, CUBAŁA WIESŁAW JERZY, Walaszek Michał, PASTUSZAK MICHAŁ, PASTUSZAK KRZYSZTOF, KWAŚNY ALEKSANDER - Neuropsychopharmacol. Rep. - 2025 : vol. 45, nr 3, art. ID e70038, s. 1-6, bibliogr. 24 poz., streszcz. ang.
  31. Non-response to short-term ketamine use for treatment-resistant depression - Walaszek Michał, CUBAŁA WIESŁAW JERZY, Kachlik Zofia, PASTUSZAK MICHAŁ, PASTUSZAK KRZYSZTOF, KWAŚNY ALEKSANDER - Pharmacol. Rep. - 2025 : vol. 77, s. 1126-1133, bibliogr. 35 poz., streszcz. ang.
  32. Regulatory alignment of psilocybin clinical trials in major depressive disorder on ClinicalTrials.gov: a cross-sectional analysis - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, Pruc Michal, Gaca Zuzanna, Szarpak Lukasz, CUBAŁA WIESŁAW J. - Pharmacopsychiatry - 2025 : vol. 58, nr 4, s. 187-197, bibliogr. 44 poz., streszcz. ang.
  33. Safety and tolerability of NN-dimethyltryptamine (DMT) in healthy volunteers and Major Depressive Disorder (MDD) patients: a systematic review of early-phase clinical trials - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, CUBAŁA WIESŁAW JERZY - Prog. Neuropsychopharmacol. Biol. Psychiatr. - 2025 : vol. 140, art. ID 111419, s. 1-17, bibliogr. [32] poz., streszcz. ang.
  34. Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials - ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, Pruc Michał, Gaca Zuzanna, Szarpak Łukasz, CUBAŁA WIESŁAW J. - Psychiatr. Res. - 2025 : vol. 344, art. ID 116337, s. 1-10, bibliogr. [27] poz., streszcz. ang.
  35. Diversity of central nervous system manifestations in Sjogren's Disease: a case-based review - JASKÓLSKA MARTA, Rytlewska Magdalena, Dułak Natalia Aleksandra, Ulanowski Miłosz, KWARCIANY MARIUSZ, WIGLUSZ MARIUSZ STANISŁAW, CUBAŁA WIESŁAW JERZY, CHMIELEWSKI MICHAŁ - Rheumatol. Int. - 2025 : vol. 45, nr 2, art. nr 35, s. 1-14, bibliogr. 55 poz., streszcz. ang.
  36. Ketamine dosing formula in treatment-resistant bipolar depression - KWAŚNY ALEKSANDER, CUBAŁA WIESŁAW JERZY, WILKOWSKA ALINA - Ther. Adv. Psychopharmacol. - 2025 : vol. 15, s. 1-9, bibliogr. 26 poz., streszcz. ang.
  37. The search for consistency in residual symptoms in major depressive disorder: a narrative review - Pastuszak Michał, CUBAŁA WIESŁAW JERZY, KWAŚNY ALEKSANDER, MECHLIŃSKA AGNIESZKA - J. Pers. Med. - 2024 : vol. 14, nr 8, art. ID 828, s. 1-12, bibliogr. 51 poz., streszcz. ang.
  38. Treatment-emergent symptoms during short-term ketamine administration in treatment-resistant bipolar depression: a retrospective cross-sectional descriptive study - Pastuszak Michał, CUBAŁA WIESŁAW JERZY, KWAŚNY ALEKSANDER - Asian J. Psychiatr. - 2024 : vol. 99, art. ID 104159, s. 1-5, bibliogr. [27] poz., streszcz. ang.
  39. Single arketamine in treatment resistant depression: presentation of 3 cases with regard to sick-leave duration - WŁODARCZYK ADAM, SŁUPSKI JAKUB, SZARMACH JOANNA, CUBAŁA WIESŁAW JERZY - Asian J. Psychiatr. - 2024 : vol. 96, art. ID 104016, s. 1-4, bibliogr. [11] poz., streszcz. ang.
  40. Analysis of clinical and genetic factors of obesity and psoriasis concomitance - the influence of body mass composition, prevalence of mood disorders, environmental factors and FTO gene polymorphisms (rs9939609, rs1558902) - CZARNECKA ANNA, PURZYCKA-BOHDAN DOROTA, ZABŁOTNA MONIKA, NOWICKI ROMAN J., RĘBAŁA KRZYSZTOF, BOHDAN MICHAŁ, GRUCHAŁA MARCIN, WILKOWSKA ALINA, SZCZERKOWSKA-DOBOSZ ANETA - Biomedicines - 2024 : vol. 12, nr 3, art. ID 517, s. 1-19, bibliogr. 56 poz., streszcz. ang.
  41. Ketamine and lamotrigine combination in mood disorders - call for real-world evidence reporting - WILKOWSKA ALINA, WIGLUSZ MARIUSZ S., CUBAŁA WIESŁAW J. - Bipolar Disord. - 2024 : vol. 26, nr 8, s. 820, bibliogr. 3 poz.
  42. Anhedonia in bipolar depression treated with ketamine - WILKOWSKA ALINA, WIGLUSZ MARIUSZ S., Arciszewska-Leszczuk Aleksandra, GAŁUSZKO-WĘGIELNIK MARIA, CUBAŁA WIESŁAW J. - Bipolar Disord. - 2024 : vol. 26, nr 4, s. 356-363, bibliogr. 37 poz., streszcz. ang.
  43. Residual depressive symptoms in treatment-resistant bipolar depression following short-term ketamine administration - Pastuszak Michał, CUBAŁA WIESŁAW JERZY, KWAŚNY ALEKSANDER - Drugs-Real World Outcomes - 2024 : vol. 11, nr 4, s. 565-571, bibliogr. 26 poz., streszcz. ang.
  44. Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder - Gaca Zuzanna, Pruc Michal, ŚWIECZKOWSKI DAMIAN, KWAŚNY ALEKSANDER, Szarpak Lukasz, CUBAŁA WIESŁAW J. - Eur. Neuropsychopharmacol. - 2024 : vol. 86, s. 18-19, bibliogr. [4] poz.
  45. Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review - KWAŚNY ALEKSANDER, Kwaśna Julia, WILKOWSKA ALINA, SZARMACH JOANNA, SŁUPSKI JAKUB, WŁODARCZYK ADAM, CUBAŁA WIESŁAW JERZY - Eur. Neuropsychopharmacol. - 2024 : vol. 86, s. 20-34, bibliogr. [82] poz., streszcz. ang.
  46. Attitudes and perceptions of early-career psychiatrists towards Eletroconvulsive Therapy (ECT) in Poland: a call for enhanced training and guidelines - Gołębiewska M. E., WILKOWSKA ALINA, CUBAŁA WIESŁAW J., Pinto da Costa M. - Eur. Psychiatr. - 2024 : vol. 67, suppl. 1, s. S705-S706
  47. Early career psychiatrists' perceptions of and training experience in electroconvulsive therapy: a cross-sectional survey across Europe - Ţăpoi Cristiana, Alexander Laith, de Filippis Renato, Agorastos Agorastos, Almeida Diogo, Bhatia Gautam, Erzin Gamze, Gołębiewska Martyna Ewa, Metaj Enita, Medved Sara, Mieze Krista, Milutinović Miloš, Noël Camille, Pushko Antonina, Salas David Gurrea, Compaired Sanchez Alejandro, WILKOWSKA ALINA, Wolthusen Rick P. F., Pinto da Costa Mariana - Eur. Psychiatr. - 2024 : vol. 67, nr 1, art. ID e86, s. 1-9, bibliogr. 61 poz., streszcz. ang.
  48. The impact of war on the development and progression of arterial hypertension and cardiovascular disease: protocol of a prospective study among Ukrainian female refugees - SHALIMOVA ANNA, Stoenoiu M. S., CUBAŁA WIESŁAW JERZY, BURNIER MICHEL, Persu A., NARKIEWICZ KRZYSZTOF - Front. Cardiovasc. Med. - 2024 : vol. 10, art. ID 1324367, s. 1-9, bibliogr. 32 poz., streszcz. ang.
  49. Short-term safety and tolerability profile of 5-methoxy-N,N- dimethyltryptamine in human subjects: a systematic review of clinical trials - KWAŚNY ALEKSANDER, WILKOWSKA ALINA, CUBAŁA WIESŁAW JERZY - Front. Psychiatry - 2024 : vol. 15, art. ID 1477996, s. 1-9, bibliogr. 27 poz., streszcz. ang.
  50. Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression - Kwaśny Aleksander, CUBAŁA WIESŁAW JERZY, WŁODARCZYK ADAM - Front. Psychiatry - 2024 : vol. 15, art. ID 1334293, s. 1-6, bibliogr. 22 poz., streszcz. ang.
  51. Association of high blood pressure with post-traumatic stress disorder in Ukrainian women refugees - SHALIMOVA ANNA, Stoenoiu Maria Simona, Manolache Narcis-George, CUBAŁA WIESŁAW J., BURNIER MICHEL, NARKIEWICZ KRZYSZTOF, Persu Alexandre - Hypertension - 2024 : vol. 81, nr 10, s. e128-e131, bibliogr. 7 poz., streszcz. ang.
  52. Safety profile of pimavanserin therapy in elderly patients with neurodegenerative disease-related neuropsychiatric symptoms: a phase 3B study - Alva Gus, CUBAŁA WIESŁAW J., Berrio Ana, Coate Bruce, Abler Victor, Pathak Sanjeev - J. Alzheimers Dis. - 2024 : vol. 98, nr 1, s. 265-274, bibliogr. 28 poz., streszcz. ang.
  53. Intravenous ketamine infusions in patients with depression and epilepsy: case series - WIGLUSZ MARIUSZ STANISŁAW, Chmielewska Zuzanna, CUBAŁA WIESŁAW JERZY - J. Clin. Neurosci. - 2024 : vol. 130, art. ID 110908, s. 1-5, bibliogr. 36 poz., streszcz. ang.
  54. Worldwide internet trends in the public interest related to skin whitening and bleaching creams - Dobosz Maria, Radziwon Jakub, CUBAŁA WIESŁAW JERZY - J. Cosmet. Laser Ther. - 2024 : vol. 26, nr 1-4, s. 26-30, bibliogr. 32 poz., streszcz. ang.
  55. Heterogenic bacterial resistance to low concentration of ketamine - JARZEMBOWSKI TOMASZ, DACA AGNIESZKA, ZYŚK MARLENA, CUBAŁA WIESŁAW, PIECHOWICZ LIDIA - J. Glob. Antimicrob. Resist. - 2024 : vol. 39, suppl., s. 30-31
  56. Severity of emotional distress and post-traumatic stress disorder among hypertensive and normotensive Ukrainian refugee women in different living conditions - SHALIMOVA ANNA, Stoenoiu Maria S., CUBAŁA WIESŁAW J., BURNIER MICHEL, Persu Alexandre, NARKIEWICZ KRZYSZTOF - J. Hypertens. - 2024 : vol. 42, suppl. 1, s. e312
  57. Magnesium level and impulsivity during ketamine administration for treatment-resistant mood disorders - SŁUPSKI JAKUB, WŁODARCZYK ADAM, Górska Natalia, SZARMACH JOANNA, SŁUPSKA ANITA, Pilecka Karolina, KWAŚNY ALEKSANDER, Kowalska Żaneta, CUBAŁA WIESŁAW JERZY - Magnes. Res. - 2024 : vol. 37, nr 3, s. 40-48, bibliogr. 34 poz., streszcz. ang.
  58. Low-carbohydrate diet as a disease modifier for relapse prevention of treatment-resistant depression. S potlight on neuroplasticity and brain-derived neurotrophic factor - Kachlik Zofia, Walaszek Michał, CUBAŁA WIESŁAW JERZY - Med. Hypotheses - 2024 : vol. 187, art. ID 111356, s. 1-6, bibliogr. 79 poz., streszcz. ang.
  59. Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: an open-label extension study - CUBAŁA WIESŁAW, Berrio A., Chi-Burris K., Alva G., Chrones L., Pathak S. - Mov. Disord. - 2024 : vol. 39, suppl. 1, s. S350
  60. Effect of series of periodic limb movements in sleep on blood pressure, heart rate and high frequency heart rate variability - MAŁKIEWICZ MARTA A., GRZYWIŃSKA MAŁGORZATA, MALINOWSKI KRZYSZTOF S., Partinen Eemil, Partinen Markku, CUBAŁA WIESŁAW J., WINKLEWSKI PAWEŁ J., SIEMIŃSKI MARIUSZ - Neurol. Neurochir. Pol. - 2024 : vol. 58, nr 2, s. 167-175, bibliogr. 63 poz., streszcz. ang.
  61. Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention - Walaszek Michał, Kachlik Zofia, CUBAŁA WIESŁAW JERZY - Nutr. Neurosci. - 2024 : vol. 27, nr 10, s. 1185-1198, bibliogr. 124 poz., streszcz. ang.
  62. The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder - Kwaśna Julia, CUBAŁA WIESŁAW JERZY, KWAŚNY ALEKSANDER, WILKOWSKA ALINA - Pharmacol. Rep. - 2024 : vol. 76, nr 6, s. 1318-1324, bibliogr. 26 poz., streszcz. ang.
  63. Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment - KWAŚNY ALEKSANDER, CUBAŁA WIESŁAW JERZY, WŁODARCZYK ADAM, PASTUSZAK KRZYSZTOF - Pharmacol. Rep. - 2024 : vol. 76, nr 6, s. 1325-1332, bibliogr. 30 poz., streszcz. ang.
  64. Interictal dysphoric disorder in epilepsy and its relationship with specific clinical and demographic variables - GRZEGORZEWSKA AGATA MARIA, WIGLUSZ MARIUSZ STANISŁAW, JAKUSZKOWIAK-WOJTEN KATARZYNA, CUBAŁA WIESŁAW JERZY, WŁODARCZYK ADAM, SZARMACH JOANNA - Psychiatr. Clin. Psychopharmacol. - 2024 : vol. 34, nr 2, s. 191-196, bibliogr. 34 poz., streszcz. ang.
  65. Polski standard leczenia racemiczną ketaminą pacjentów z zaburzeniami depresyjnymi opracowany przez zespół roboczy powołany przez Konsultanta Krajowego w dziedzinie psychiatrii - Gałecki Piotr, Bliźniewska-Kowalska Katarzyna, CUBAŁA WIESŁAW JERZY, Depukat Anna, Mosiołek Anna, Rybakowski Janusz, Samochowiec Jerzy, Sobolewski Bogusław, Szulc Agata, Dudek Dominika - Psychiatr. Pol. - 2024 : vol. 58, nr 3, s. 377-401, bibliogr. 69 poz., streszcz. ang.
  66. Polish-language adaptation of the Oxford Depression Questionnaire (ODQ) - CUBAŁA WIESŁAW JERZY, MILSKA-MUSA KATARZYNA ALICJA, LANDOWSKI JERZY, WIGLUSZ MARIUSZ STANISŁAW, WŁODARCZYK ADAM, SZARMACH JOANNA, SPRINGER JANUSZ, SŁUPSKI JAKUB - Psychiatr. Psychol. Klin. - 2024 : vol. 24, nr 3, s. 240-244, bibliogr. [16] poz., streszcz. ang., pol.
  67. Comment on: "Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: the Bio-K multicenter trial" - Kwaśna Julia, KWAŚNY ALEKSANDER, Bychowski Mateusz, Kwaśna Magdalena, Pastuszak Michał - Psychiatr. Res. - 2024 : vol. 337, art. ID 115987, s. 1-2, bibliogr. [5] poz.
  68. An expert review of clozapine in Eastern European countries: use, regulations and pharmacovigilance - Sagud Marina, Breznoscakova Dagmar, Celofiga Andreja, Chihai Jana, Chkonia Eka, Ristic Ignjatovic Dragana, Injac Stevovic Lidija, Kopecek Miloslav, Kurvits Katrin, Kuzo Nazar, Lazáry Judit, Mazaliauskienė Ramunė, Mladina Perisa Djurdjica, Novotni Antoni, Panov Georgi, Pikirenia Uladzimir, Rădulescu Flavian Ştefan, Sukiasyan Samvel Grant, Taube Māris, Tomori Sonila, WILKOWSKA ALINA, De Las Cuevas Carlos, Sanz Emilio J., de Leon Jose - Schizophr. Res. - 2024 : vol. 268, s. 53-59, bibliogr. [30] poz., streszcz. ang.
  69. Residual hypersomnia in unipolar and bipolar depression: a systematic review - Kwaśna Julia, KWAŚNY ALEKSANDER, WILKOWSKA ALINA, Bychowski Mateusz, CUBAŁA WIESŁAW JERZY - World J. Biol. Psychiatr. - 2024 : vol. 25, nr 10, s. 575-591, bibliogr. [64] poz., streszcz. ang.
Aktualizacja strony: 31.05.2022
Helpdesk IT